메뉴 건너뛰기




Volumn 3, Issue 1, 2008, Pages

Development of automated brightfield double in Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in Situ hybridization (FISH)

Author keywords

[No Author keywords available]

Indexed keywords


EID: 55349128939     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-41     Document Type: Article
Times cited : (93)

References (44)
  • 2
    • 3042622482 scopus 로고    scopus 로고
    • HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues
    • 10.3816/CBC.2004.n.011. 15140287
    • HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. MA Owens BC Horten MM Da Silva, Clin Breast Cancer 2004 5 63 69 10.3816/CBC.2004.n.011 15140287
    • (2004) Clin Breast Cancer , vol.5 , pp. 63-69
    • Owens, M.A.1    Horten, B.C.2    Da Silva, M.M.3
  • 4
    • 34547095237 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-postive breast cancer
    • 10.1002/cncr.22806. 17592827
    • Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-postive breast cancer. LP Garrison Jr D Lubeck D Lalla V Paton A Dueck EA Perez, Cancer 2007 110 489 498 10.1002/cncr.22806 17592827
    • (2007) Cancer , vol.110 , pp. 489-498
    • Garrison Jr., L.P.1    Lubeck, D.2    Lalla, D.3    Paton, V.4    Dueck, A.5    Perez, E.A.6
  • 5
    • 33847038462 scopus 로고    scopus 로고
    • Trastuzumab in adjuvant breast cancer therapy. a model based cost-effectivemess analysis
    • 10.1080/02841860601096841. 17453363
    • Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectivemess analysis. J Norum JA Olsen EA Wist PE Lønning, Acta Oncol 2007 46 153 164 10.1080/02841860601096841 17453363
    • (2007) Acta Oncol , vol.46 , pp. 153-164
    • Norum, J.1    Olsen, J.A.2    Wist, E.A.3    Lønning, P.E.4
  • 6
    • 34548674957 scopus 로고    scopus 로고
    • Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer
    • 17723955
    • Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer. F Fagnani X Colin P Arveux B Coudert JL Misset, Bull Cancer 2007 94 711 720 17723955
    • (2007) Bull Cancer , vol.94 , pp. 711-720
    • Fagnani, F.1    Colin, X.2    Arveux, P.3    Coudert, B.4    Misset, J.L.5
  • 7
    • 34248376048 scopus 로고    scopus 로고
    • Cost effectiveness of trastuzumab in the early breast cancer: A lifetime model
    • 10.2165/00019053-200725050-00006
    • Cost effectiveness of trastuzumab in the early breast cancer: a lifetime model. JA Millar MJ Millward, Pharmocoeconomics 2007 25 429 442 10.2165/00019053-200725050-00006
    • (2007) Pharmocoeconomics , vol.25 , pp. 429-442
    • Millar, J.A.1    Millward, M.J.2
  • 8
    • 34548481766 scopus 로고    scopus 로고
    • 111Indium-trastuzumab visualizes myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity
    • 10.1016/j.ejca.2007.06.024. 17719768
    • 111Indium-trastuzumab visualizes myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity. MA de Korte EG de Vries MN Lub-de Hooge PL Jager JA Gietema WT van der Graaf WJ Sluiter DJ van Veldhuisen TM Suter DT Sleijfer PJ Perik, Eur J Cancer 2007 43 2046 2051 10.1016/j.ejca.2007.06.024 17719768
    • (2007) Eur J Cancer , vol.43 , pp. 2046-2051
    • De Korte, M.A.1    De Vries, E.G.2    Lub-De Hooge, M.N.3    Jager, P.L.4    Gietema, J.A.5    Der Van Graff, W.T.6    Sluiter, W.J.7    Van Veldhuisen, D.J.8    Suter, T.M.9    Sleijfer, D.T.10    Perik, P.J.11
  • 10
    • 33644508444 scopus 로고    scopus 로고
    • Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: A study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
    • 15743507. 10.1186/bcr996
    • Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry. M Salido I Tusquets JM Corominas M Suarez B Espinet C Corzo M Bellet X Fabregat S Serrano F Solé Breast Cancer Res 2005 7 R267 R273 15743507 10.1186/bcr996
    • (2005) Breast Cancer Res , vol.7
    • Salido, M.1    Tusquets, I.2    Corominas, J.M.3    Suarez, M.4    Espinet, B.5    Corzo, C.6    Bellet, M.7    Fabregat, X.8    Serrano, S.9    Solé, F.10
  • 12
    • 40449103809 scopus 로고    scopus 로고
    • Comparison of different commercial kits for HER2 testing in breast cancer: Looking for the accurate cut-off for amplification
    • 17908324
    • Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cut-off for amplification. A Cayre F Mishellany N Lagarde F Penault-Llorca, Breast Cancer Res 2007 17908324
    • (2007) Breast Cancer Res
    • Cayre, A.1    Mishellany, F.2    Lagarde, N.3    Penault-Llorca, F.4
  • 13
    • 33645326209 scopus 로고    scopus 로고
    • Unlocking pathology archives for molecular genetic studies: A realizable method to generate probes for chromogenic and fluorescent in situ hybridization
    • 10.1038/labinvest.3700390. 16446704
    • Unlocking pathology archives for molecular genetic studies: a realizable method to generate probes for chromogenic and fluorescent in situ hybridization. MB Lambros PT Simpson C Jones R Natrajan C Westbury D Steele K Savage A Mackay FC Schmitt A Ashworth JS Reis-Filho, Lab Invest 2006 86 398 408 10.1038/labinvest.3700390 16446704
    • (2006) Lab Invest , vol.86 , pp. 398-408
    • Lambros, M.B.1    Simpson, P.T.2    Jones, C.3    Natrajan, R.4    Westbury, C.5    Steele, D.6    Savage, K.7    MacKay, A.8    Schmitt, F.C.9    Ashworth, A.10    Reis-Filho, J.S.11
  • 14
    • 33745986327 scopus 로고    scopus 로고
    • HER2 testing by local, central, and reference laboratories in specimens from the north central cancer treatment group N9831 intergroup adjuvant trial
    • 10.1200/JCO.2005.03.4744. 16809727
    • HER2 testing by local, central, and reference laboratories in specimens from the north central cancer treatment group N9831 intergroup adjuvant trial. EA Perez VJ Suman NE Davidson S Martino PA Kaufman WL Lingle PJ Flynn JN Ingle D Visscher RB Jenkins, J Clin Oncol 2006 24 3032 3038 10.1200/JCO.2005.03.4744 16809727
    • (2006) J Clin Oncol , vol.24 , pp. 3032-3038
    • Perez, E.A.1    Suman, V.J.2    Davidson, N.E.3    Martino, S.4    Kaufman, P.A.5    Lingle, W.L.6    Flynn, P.J.7    Ingle, J.N.8    Visscher, D.9    Jenkins, R.B.10
  • 18
    • 0036082527 scopus 로고    scopus 로고
    • Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma
    • 10.1038/modpathol.3880582. 12065780
    • Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. J Zhao R Wu A Au A Marquez Y Yu Z Shi, Mod Pathol 2002 15 657 665 10.1038/modpathol.3880582 12065780
    • (2002) Mod Pathol , vol.15 , pp. 657-665
    • Zhao, J.1    Wu, R.2    Au, A.3    Marquez, A.4    Yu, Y.5    Shi, Z.6
  • 19
    • 7444228551 scopus 로고    scopus 로고
    • Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome
    • 10.1038/modpathol.3800006
    • Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome. G Peiró D Mayr P Hillemanns U Löhrs J Diebold, Mod Pathol 2004 17 277 287 10.1038/modpathol.3800006
    • (2004) Mod Pathol , vol.17 , pp. 277-287
    • Peiró, G.1    Mayr, D.2    Hillemanns, P.3    Löhrs, U.4    Diebold, J.5
  • 20
    • 0141853741 scopus 로고    scopus 로고
    • Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray
    • 10.1097/01.MP.0000086487.78558.7D. 13679458
    • Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray. K Park J Kim S Lim S Han JY Lee, Mod Pathol 2003 16 937 943 10.1097/01.MP.0000086487.78558.7D 13679458
    • (2003) Mod Pathol , vol.16 , pp. 937-943
    • Park, K.1    Kim, J.2    Lim, S.3    Han, S.4    Lee, J.Y.5
  • 21
    • 33645298450 scopus 로고    scopus 로고
    • Chromogenic in-situ hybridization: A viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm
    • 10.1038/modpathol.3800555. 16444193
    • Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm. WM Hanna K Kwok, Mod Pathol 2006 19 481 487 10.1038/modpathol.3800555 16444193
    • (2006) Mod Pathol , vol.19 , pp. 481-487
    • Hanna, W.M.1    Kwok, K.2
  • 22
    • 34247882706 scopus 로고    scopus 로고
    • Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer
    • 10.1016/j.yexmp.2007.01.002. 17335803
    • Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer. N Todorović- Raković D Jovanović Z Nesković-Konstantinović D Nikolić-Vukosavljević Exp Mol Pathol 2007 82 262 268 10.1016/j.yexmp.2007.01.002 17335803
    • (2007) Exp Mol Pathol , vol.82 , pp. 262-268
    • Todorović-Raković, N.1    Jovanović, D.2    Nesković-Konstantinović, Z.3    Nikolić-Vukosavljević, D.4
  • 23
    • 0036094229 scopus 로고    scopus 로고
    • Gold facilitated in situ hybridization (GOLDFISH): A bright field autometallographic alternative to fluorescence in situ hybridization for detection of HER-2/neu gene amplification
    • Gold facilitated in situ hybridization (GOLDFISH): A bright field autometallographic alternative to fluorescence in situ hybridization for detection of HER-2/neu gene amplification. R Tubbs J Pettay M Skacel R Powell M Stoler P Roche J Hainfeld, Amer J Pathol 2002 160 1589 1595
    • (2002) Amer J Pathol , vol.160 , pp. 1589-1595
    • Tubbs, R.1    Pettay, J.2    Skacel, M.3    Powell, R.4    Stoler, M.5    Roche, P.6    Hainfeld, J.7
  • 24
    • 0036307977 scopus 로고    scopus 로고
    • Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma
    • 10.1097/00000478-200207000-00009. 12131158
    • Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma. R Tubbs M Skacel J Pettay R Powell J Myles D Hicks J Sreenan P Roche MH Stoler J Hainfeld, Am J Surg Pathol 2002 26 908 913 10.1097/00000478-200207000-00009 12131158
    • (2002) Am J Surg Pathol , vol.26 , pp. 908-913
    • Tubbs, R.1    Skacel, M.2    Pettay, J.3    Powell, R.4    Myles, J.5    Hicks, D.6    Sreenan, J.7    Roche, P.8    Stoler, M.H.9    Hainfeld, J.10
  • 25
    • 16644396502 scopus 로고    scopus 로고
    • Novel bright field molecular morphology methods for detection of HER2 gene amplification
    • 10.1007/s10735-004-2191-9. 15614612
    • Novel bright field molecular morphology methods for detection of HER2 gene amplification. R Tubbs J Pettay D Hicks M Skacel R Powell T Grogan J Hainfeld, J Mol Histol 2004 35 589 594 10.1007/s10735-004-2191-9 15614612
    • (2004) J Mol Histol , vol.35 , pp. 589-594
    • Tubbs, R.1    Pettay, J.2    Hicks, D.3    Skacel, M.4    Powell, R.5    Grogan, T.6    Hainfeld, J.7
  • 26
    • 27244440343 scopus 로고    scopus 로고
    • Analytical validation and interobserver reproducibility of EnzMet GenePro: A second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast
    • 10.1097/01.pas.0000172294.67409.4f. 16224218
    • Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast. E Downs-Kelly J Pettay D Hicks M Skacel B Yoder L Rybicki J Myles J Sreenan P Roche R Powell J Hainfeld T Grogan R Tubbs, Am J Surg Pathol 2005 29 1505 1511 10.1097/01.pas.0000172294.67409.4f 16224218
    • (2005) Am J Surg Pathol , vol.29 , pp. 1505-1511
    • Downs-Kelly, E.1    Pettay, J.2    Hicks, D.3    Skacel, M.4    Yoder, B.5    Rybicki, L.6    Myles, J.7    Sreenan, J.8    Roche, P.9    Powell, R.10    Hainfeld, J.11    Grogan, T.12    Tubbs, R.13
  • 28
    • 35748985896 scopus 로고    scopus 로고
    • Comparison of automated silver enhanced in situ hybridization (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists
    • 10.1007/s00428-007-0424-5. 17562074
    • Comparison of automated silver enhanced in situ hybridization (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. M Dietel IO Ellis H Höfler H Kreipe H Moch A Dankof K Kölble G Kristiansen, Virchows Arch 2007 451 19 25 10.1007/s00428-007-0424-5 17562074
    • (2007) Virchows Arch , vol.451 , pp. 19-25
    • Dietel, M.1    Ellis, I.O.2    Höfler, H.3    Kreipe, H.4    Moch, H.5    Dankof, A.6    Kölble, K.7    Kristiansen, G.8
  • 30
    • 15544382365 scopus 로고    scopus 로고
    • Assessment of the HER2 Status in Breast Cancer by Fluorescence In-Situ Hybridization (FISH): A Technical Review with Interpretative Guidelines
    • 10.1016/j.humpath.2004.11.010. 15791569
    • Assessment of the HER2 Status in Breast Cancer by Fluorescence In-Situ Hybridization (FISH): a Technical Review with Interpretative Guidelines. DG Hicks RR Tubbs, Hum Pathol 2005 36 250 261 10.1016/j.humpath.2004.11.010 15791569
    • (2005) Hum Pathol , vol.36 , pp. 250-261
    • Hicks, D.G.1    Tubbs, R.R.2
  • 33
    • 34250811980 scopus 로고    scopus 로고
    • HER2 testing in the UK: Consensus from a national consultation
    • National HER2 Consultation Steering Group, 10.1136/jcp.2006.044321. 17322344
    • HER2 testing in the UK: consensus from a national consultation. M Dowsett AM Hanby R Laing R Walker National HER2 Consultation Steering Group, J Clin Pathol 2007 60 685 689 10.1136/jcp.2006.044321 17322344
    • (2007) J Clin Pathol , vol.60 , pp. 685-689
    • Dowsett, M.1    Hanby, A.M.2    Laing, R.3    Walker, R.4
  • 34
    • 34249822213 scopus 로고    scopus 로고
    • Standardizing slide-based assays in breast cancer: Hormone receptors, HER2, and sentinel lymph nodes
    • 10.1158/1078-0432.CCR-06-2522. 17504980
    • Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes. JS Ross WF Symmans L Pusztai GN Hortobagyi, Clin Cancer Res 2007 13 2831 2835 10.1158/1078-0432.CCR-06-2522 17504980
    • (2007) Clin Cancer Res , vol.13 , pp. 2831-2835
    • Ross, J.S.1    Symmans, W.F.2    Pusztai, L.3    Hortobagyi, G.N.4
  • 36
    • 33751382730 scopus 로고    scopus 로고
    • Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: A feasibility study
    • 10.1097/01.pai.0000213101.26193.f1. 17122642
    • Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: a feasibility study. RR Tubbs JD Pettay E Swain PC Roche W Powell DG Hicks T Grogan, Appl Immunohistochem Mol Morphol 2006 14 436 440 10.1097/01.pai. 0000213101.26193.f1 17122642
    • (2006) Appl Immunohistochem Mol Morphol , vol.14 , pp. 436-440
    • Tubbs, R.R.1    Pettay, J.D.2    Swain, E.3    Roche, P.C.4    Powell, W.5    Hicks, D.G.6    Grogan, T.7
  • 37
    • 33745346284 scopus 로고    scopus 로고
    • HER-2 status in breast cancer: Correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system
    • 10.1097/01.pai.0000150516.75567.13. 16785779
    • HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. A Ciampa B Xu G Ayata D Baiyee J Wallace M Wertheimer K Edmiston A Khan, Appl Immunohistochem Mol Morphol 2006 14 132 137 10.1097/01.pai.0000150516.75567.13 16785779
    • (2006) Appl Immunohistochem Mol Morphol , vol.14 , pp. 132-137
    • Ciampa, A.1    Xu, B.2    Ayata, G.3    Baiyee, D.4    Wallace, J.5    Wertheimer, M.6    Edmiston, K.7    Khan, A.8
  • 40
    • 0028067041 scopus 로고
    • A novel triple-color detection procedure for brightfield microscopy, combining in situ hybridization with immunocytochemistry
    • 7930513
    • A novel triple-color detection procedure for brightfield microscopy, combining in situ hybridization with immunocytochemistry. EJ Speel MP Jansen FC Ramaekers AH Hopman, J Histochem Cytochem 1994 42 1299 1307 7930513
    • (1994) J Histochem Cytochem , vol.42 , pp. 1299-1307
    • Speel, E.J.1    Jansen, M.P.2    Ramaekers, F.C.3    Hopman, A.H.4
  • 41
    • 0030779625 scopus 로고    scopus 로고
    • Multi-colour brightfield in situ hybridization on tissue sections
    • 10.1007/s004180050168. 9387920
    • Multi-colour brightfield in situ hybridization on tissue sections. AHN Hopman S Claessen EJM Speel, Histochem Cell Biol 1997 108 291 298 10.1007/s004180050168 9387920
    • (1997) Histochem Cell Biol , vol.108 , pp. 291-298
    • Hopman, A.H.N.1    Claessen, S.2    Speel, E.J.M.3
  • 42
    • 33747883996 scopus 로고    scopus 로고
    • Dual-colour chromogenic in situ hybridization for testing HER-2 oncogene amplification in archival breast tumors
    • 10.1002/path.2022. 16823892
    • Dual-colour chromogenic in situ hybridization for testing HER-2 oncogene amplification in archival breast tumors. M Laakso M Tanner J Isola, J Pathol 2006 210 3 9 10.1002/path.2022 16823892
    • (2006) J Pathol , vol.210 , pp. 3-9
    • Laakso, M.1    Tanner, M.2    Isola, J.3
  • 44
    • 34548017672 scopus 로고    scopus 로고
    • Inconsistency of HER2 test raises questions
    • 10.1093/jnci/djm075. 17623788
    • Inconsistency of HER2 test raises questions. RS Tuma, J Natl Cancer Inst 2007 99 1064 1065 10.1093/jnci/djm075 17623788
    • (2007) J Natl Cancer Inst , vol.99 , pp. 1064-1065
    • Tuma, R.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.